Should kids living with obesity be on GLP-1s? New global guidance says yes — in some cases

Global health authorities have introduced the first comprehensive guidelines for managing childhood obesity, emphasizing the use of GLP-1 treatments in certain situations for kids and teens. While acknowledging the potential benefits, the guidance is cautious, setting strict criteria for their use to ensure safety and efficacy. This marks a significant step in addressing the rising issue of youth obesity, which has profound implications for long-term health outcomes and societal costs related to chronic diseases. The guidelines aim to provide healthcare professionals with a clear framework to manage this critical health challenge.